Concepedia

Ching-Wen Kuo

CK

Statistics

Publications

3

Citations

192

H-Index

3

Active since

2014

Affiliations

University of Auckland(Current)

Cancer Society of New Zealand

Chi Mei Medical Center

National Cheng Kung University

Deakin University

Ching-Wen Kuo is an author at University of Auckland specializing in oncology, breast cancer resistance mechanisms, and molecular oncology.

Publications per year

2014–2017

3

Publications

3

<scp>YM155</scp> down‐regulates survivin and <scp>XIAP</scp>, modulates autophagy and induces autophagy‐dependent <scp>DNA</scp> damage in breast cancer cells

Siao Muk Cheng, Yung-Chieh Chang, C Y Liu et al. · British Journal of Pharmacology · 2014 · 93 citations · Full text

, , +17

Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells

Jane Ying-Chieh Lee, Ching-Wen Kuo, Shing-Ling Tsai et al. · Frontiers in Pharmacology · 2016 · 64 citations · Full text

, , +17

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells

Wen-Tsung Huang, Yu‐Hsuan Tsai, Shang‐Hung Chen et al. · Frontiers in Pharmacology · 2017 · 35 citations · Full text

, , +17

1–3 of 3